Related references
Note: Only part of the references are listed.Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
Signe Modvig et al.
PLOS ONE (2013)
Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients
Shi-Rong Wen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
Bibiana Bielekova et al.
PLOS ONE (2012)
Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
Thomas B. Martins et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
Refik Pul et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome
Vladimira Sladkova et al.
NEUROLOGICAL RESEARCH (2011)
Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis
Makoto Hirotani et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis
Rinze F. Neuteboom et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse
Dagmara M. Mirowska-Guzel et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production
Adi Vaknin-Dembinsky et al.
JOURNAL OF IMMUNOLOGY (2006)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
H Bartosik-Psujek et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Increased CXCL8 (IL-8) expression in multiple sclerosis
BT Lund et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis
F Bagnato et al.
NEUROLOGICAL SCIENCES (2003)
CSF and serum orosomucoid (α-1-acid glycoprotein) in patients with multiple sclerosis:: a comparison among particular subgroups of MS patients
P Adam et al.
CLINICA CHIMICA ACTA (2003)
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
D Franciotta et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Share Paper
